Beyond Air announced preliminary Q3 2026 revenue of $2.3 million, marking a 30% increase from the previous quarter and 27% growth year-over-year, driven by strong adoption of its first-generation LungFit PH nitric oxide system. The company reaffirmed its revenue guidance of $8 million for 2026 and $16-$18 million for 2027, which includes expected sales from the second-generation LungFit PH pending FDA approval. The second-generation system is under FDA review, and its approval could significantly boost demand. Beyond Air aims to become a single-source nitric oxide provider with enhanced transport capabilities, improving hospital adoption and operational efficiency.
Beyond Air's preliminary Q3 2026 revenue shows strong growth. For readers following the health sector, here is Pluang's market snapshot as of Oct 08, 2026 18:43 WIB: Out of 128 US health stocks, 29 rose and 91 fell. Notable movers include WGS at USD 67.00 with a 2.23% drop, ROIV at USD 34.75 down 2.20%, and RXRX at USD 4.18 down 2.11%, with RXRX seeing 95% sell activity and a typical hold time of 22 days on Pluang.
MIND, an AI-native data loss prevention (DLP) platform, was named "Data Loss Prevention Platform of the Year" in the 2026 CyberSecurity Breakthrough Awards. The platform uses advanced AI to discover, detect, and prevent sensitive data leaks across va...
The global Mivan construction market is projected to grow from $3.92 billion in 2025 to $7.05 billion by 2031, at a CAGR of 10.28%. Growth is fueled by demand for rapid mass housing, affordable residential projects, and faster construction enabled by...
RBC Capital has increased its price target for Amgen from $400 to $430, reflecting strong confidence in the biopharmaceutical company's future performance. Amgen's stock has outperformed both the S&P 500 and the broader medical sector recently, suppo...
Tilray Brands reported a wider-than-expected loss of $0.32 per share for Q1 fiscal 2027, missing revenue estimates with $257.1 million, though revenue grew 23% year-over-year. The company achieved record first-quarter gross profit with a 30% gross ma...
UnitedHealth Group is expected to report Q3 earnings of $4.12 per share on $111.3 billion revenue, with investors closely watching medical cost trends and Medicare Advantage membership. The company improved its medical care ratio and operating earnin...
